OMOP Concept 43289199
Nicotine 0.875 MG/HR Transdermal System [Nicotine Phase-1]
StandardDrugRxNorm ExtensionOMOP540131Branded Drug
Maps from
0
Descendants
1
Valid from
24 Aug 2017
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(14)Roll up to these when you need a wider cohort.
- 1nicotine 0.875 MG/HR
- 1Nicotine 0.875 MG/HR [Nicotine Phase-1]
- 1nicotine Topical Product
- 1nicotine Transdermal Product
- 1nicotine Transdermal System
- 1Nicotine Transdermal System [Nicotine Phase-1]
- 2nicotine
- 2nicotine; chewing gum, inhalant, nasal, sublingual, transdermal
- 2Topical Product
- 2Transdermal Product
- 3Drugs used in nicotine dependence
- 4DRUGS USED IN ADDICTIVE DISORDERS
- 5OTHER NERVOUS SYSTEM DRUGS
- 6NERVOUS SYSTEM
Narrower concepts
(1)Included automatically when you query with descendants.
Get this concept via the API
Resolve Nicotine 0.875 MG/HR Transdermal System [Nicotine Phase-1] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/43289199?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card